-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
BriaCell Therapeutics Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2021 to Q1 2024.
- BriaCell Therapeutics Corp. Nonoperating Income (Expense) for the quarter ending April 30, 2024 was $11M, a 1302% increase year-over-year.
- BriaCell Therapeutics Corp. Nonoperating Income (Expense) for the twelve months ending April 30, 2024 was $29.2M, a 1085% increase year-over-year.
- BriaCell Therapeutics Corp. annual Nonoperating Income (Expense) for 2023 was $2.97M.
- BriaCell Therapeutics Corp. annual Nonoperating Income (Expense) for 2022 was -$11.5M, a 68.9% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)